Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€1.60
02.04.24
-
02.04.25
-48.88%
13.04.24

Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
kostojunior 
02.04.24 0%
buy
Thor Industries Inc.

Start price
Target price
Perf. (%)
€96.60
29.03.24
-
29.03.25
-
30.03.24

Finanzoo 
29.03.24 50%
buy
Amazon.com Inc.

Start price
Target price
Perf. (%)
€166.46
28.03.24
€170.00
28.03.25
4.79%
14.04.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
High valuation
Traumtanz 
28.03.24 50%
sell
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€2.64
28.03.24
-
28.03.25
-40.27%
31.03.24

Risky Investment
Vassago1 
28.03.24 50%
sell
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€2.55
28.03.24
-
28.03.25
-38.27%
30.03.24

Could be worthwhile Investment >10% per year
daimler1 
28.03.24 50%
buy
Kraft Heinz Co

Start price
Target price
Perf. (%)
€33.60
28.03.24
-
28.03.25
2.41%
30.03.24

Finanzoo 
28.03.24 50%
buy
Paypal Holdings Inc

Start price
Target price
Perf. (%)
€61.72
26.03.24
€62.00
26.03.25
-2.20%
14.04.24

Top 10 in its market
Future proof or reliable business model
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Traumtanz 
26.03.24 50%
sell
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.88
26.03.24
-
26.03.25
-18.09%
31.03.24

Risky Investment
Vassago1 
26.03.24 50%
sell
SELLAS Life Sciences Group Inc

Start price
Target price
Perf. (%)
€1.06
26.03.24
-
26.03.25
-1.69%
31.03.24

Risky Investment
Vassago1 
26.03.24 50%
buy
First Solar Inc.

Start price
Target price
Perf. (%)
€178.18
22.03.24
-
-
22.03.24

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
WatchMen 
22.03.24 50%
sell
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€2.57
21.03.24
-
21.03.25
-38.64%
31.03.24

Could be very worthwhile Investment >20% year
bundfuture 
21.03.24 50%
buy
Fibrogen Inc.

Start price
Target price
Perf. (%)
€2.22
21.03.24
-
21.03.25
2.97%
29.03.24

Probably not worthwhile Investment
thomasw 
21.03.24 50%
buy
Square Inc.

Start price
Target price
Perf. (%)
€72.90
19.03.24
€85.00
19.03.25
5.62%
30.03.24

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
ROE higher than 10% per year
Very good company culture
skatcup 
19.03.24 80%
buy
Marathon Digital Holdings

Start price
Target price
Perf. (%)
€16.94
19.03.24
€22.00
19.03.25
14.24%
30.03.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Some uniques
Risky balance sheet
skatcup 
19.03.24 80%
buy
Super Micro Computer

Start price
Target price
Perf. (%)
€828.60
19.03.24
€900.00
19.03.25
18.14%
30.03.24

Could be very worthwhile Investment >20% year
Higher EBIT margin than peer group
Capable Management
Low dividend yield expected
skatcup 
19.03.24 80%
buy
Alphabet Inc. C

Start price
Target price
Perf. (%)
€158.40
19.03.24
€185.00
19.03.25
-
19.03.24

Could be very worthwhile Investment >20% year
Erno 
19.03.24 50%
sell
Super Micro Computer

Start price
Target price
Perf. (%)
€973.00
18.03.24
€666.00
18.03.25
0.61%
30.03.24

Probably not worthwhile Investment
High valuation
Low dividend yield expected
negative Cash Flow expected
kostojunior 
18.03.24 0%
buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.51
18.03.24
-
18.03.25
2.26%
30.03.24

Could be worthwhile Investment >10% per year
Wolf_of_WS 
18.03.24 50%
sell
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.51
17.03.24
€0.30
30.11.25
76.96%
28.03.24

Could be very worthwhile Investment >20% year
BiotechBee 
17.03.24 60%
sell
Stoke Therapeutics Inc

Start price
Target price
Perf. (%)
€5.80
17.03.24
€3.00
31.01.26
60.34%
25.03.24

Could be very worthwhile Investment >20% year
BiotechBee 
17.03.24 60%
buy
Verastem Inc.

Start price
Target price
Perf. (%)
€10.20
17.03.24
€16.00
30.06.26
-8.82%
19.03.24

Could be very worthwhile Investment >20% year
BiotechBee 
17.03.24 60%
buy
Albemarle Corp

Start price
Target price
Perf. (%)
€111.84
16.03.24
-
16.04.24
-3.11%
17.04.24

Could be worthwhile Investment >10% per year
Thorsten11 
16.03.24 50%
buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.51
16.03.24
€2.00
16.03.25
2.26%
30.03.24

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Low dividend yield expected
mixitrader 
16.03.24 50%
buy
Chromadex Corp

Start price
Target price
Perf. (%)
€2.22
16.03.24
€4.00
16.03.25
53.15%
30.03.24

EBIT decline/stagnation expected
Revenue decline/stagnation expected
High valuation
Low dividend yield expected
mixitrader 
16.03.24 50%
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€4.89
16.03.24
€48.00
16.03.25
-12.06%
30.03.24

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Low dividend yield expected
mixitrader 
16.03.24 50%